Ümit Görkem1, Cihan ToğruL1, Emine Arslan1, Nafiye Yılmaz2,

Slides:



Advertisements
Similar presentations
P REDICTION OF GESTATIONAL DIABETES MELLITUS BY MATERNAL FACTORS AND BIOMARKERS AT 11 TO 13 WEEKS.
Advertisements

Thyroid and Pregnancy a few interesting clinical considerations Ning-Zi Sun GIM PGY-4.
The risk of Insulin Resistence and Metabolic Syndrome among overweight/obese children born of mothers with Gestational Diabetes Mosca A., Vania A Dept.
Prenatal Care in the YK Delta Ellen Hodges, MD Chief of Staff.
THYROID DISEASE IN PREGNANCY: TREATING TWO PATIENTS Susan J. Mandel, MD MPH Perelman School of Medicine, University of Pennsylvania.
Diabetes during pregnancy
Angiogenic biomarkers for risk stratification in women with suspected preeclampsia Andreea Balan, Heather Young, Ph.D. 1, Linda Ojo, Jennifer Keller, M.D.
Diabetes in Pregnancy Screening.
Gestational diabetes mellitus (GDM), a common medical complication of pregnancy, is defined as “any degree of glucose intolerance with onset or first.
Medical University Graz Clinic of Obstetrics and Gynaecology, Medical University of Graz, Austria Gernot Desoye Intrauterine Hyperinsulinemia as Major.
IN THE NAME OF GOD. CRITICALLY APPRAISED TOPIC If there is a Non-invasive prenatal testing for aneuploidies with low FPR at first trimester? If we can.
Introduction  Preterm birth is the leading cause of perinatal death.  Handicap in children and the vast majority of mortality and morbidity relates.
Critical evaluation of the diagnosis of Gestational Diabetes Mellitus (GDM) Simon Weitzman, MD, MPH.
Normal physiology of pregnancy First trimester-Increased insulin sensitivity. Late 2 nd and 3 rd trimester insulin resistance possible associated with.
Screening for Diabetes in Pregnancy 1. Gestational Diabetes Mellitus Screening GDM, gestational diabetes mellitus. Handelsman YH, et al. Endocr Pract.
Fetal Origins of Disease Hypothesis Grace M. Egeland, Ph.D. University of Bergen.
M.G.S.D. The Gestational Diabetes Study in the Mediterranean Region Protocol C. Savona-Ventura Research Management Committee – M.G.S.D.
Diabetes in Pregnancy Burden of Disease. Diabetes in Pregnancy: Epidemiology 2%-10% of pregnancies currently are complicated by gestational diabetes mellitus.
TEMPLATE DESIGN © PREDICTIVE FACTORS OF ABNORMAL GLUCOSE TOLERANCE AT 6 WEEKS POST PARTUM IN WOMEN WITH GESTATIONAL DIABETES.
The Obstetric Implications of Diabetes & Diabesity in Malaysia G MUNISWARAN OBSTETRICIAN & GYNAECOLOGIST HOSPITAL RAJA PERMAISURI BAINUN, IPOH.
Gestational Diabetes Testing Paradigms in a Rural Office November 7, 2014.
DIABETES. Type I Diabetes: Preconception Counseling The most important aspect of the management of the Type I diabetic during pregnancy is preconception.
TEMPLATE DESIGN © Umbilical artery Pulsatility Index and different reference ranges: Does it really matter? Lo W., Mustafa.
The Relative Contribution of Prepregnancy Overweight and Obesity, Gestational Weight Gain, and IADPSG-Defined Gestational Diabetes Mellitus to Fetal Overgrowth.
Nutrition: A Lifespan Approach, by Simon Langley-Evans. © 2009 Simon Langley-Evans. 1 Learning objectives.
Diabetes in Pregnancy Ryan Agema MS III.
ANTENATAL CARE OF DIABETES IN PREGNANCY: AUDIT Rachael Read ST2 O&G Supervisor: Mr E Njiforfut Consultant.
HYPOTHYROIDISM. INTRODUCTION  Hypothyroidism is defined as a deficiency in thyroid hormone secretion and action that produces a variety of clinical signs.
Do abnormally low concentrations of Vitamin D during pregnancy contribute to postpartum depression? Anita Cintron-Rivera, PA-S School of PA Studies | Pacific.
Definition & Risk Factors of FGR FGR, also called IUGR is the term used to describe a fetus that has not reached its growth potential because of genetic.
The role of HPL in gestational diabetes
Authors: Dr. Majid Valizadeh Dr. Zahra Piri Dr. Kourosh Kamali Dr. Farnaz Mohammadian Dr. Hamidreza Amirmioghadami Presenter: Piri Z. MD.
Raised Plasma Homocysteine Concentration in Pregnancy as a Predictor of Preeclampsia Pandya B 1,2, Awan N 1, Shah S 2, Pande R 3, Prasad V 1, Myers M 3,
UOG Journal Club: March 2016 Prediction of large-for-gestational-age neonates: screening by maternal factors and biomarkers in the three trimesters of.
UOG Journal Club: July 2013 Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies M. M. Gil, M. S. Quezada, B. Bregant,
25th European Board & College of Obstetrics and Gynecology
UOG Journal Club: June 2017 Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks’ gestation: comparison with NICE.
Objective: To assess the prevalence of anemia in a sample of Jordanian pregnant women and to find out whether packed cell volume (PCV) affected by the.
Gestational Diabetes: A Big Problem Now and A Bigger Problem Later
Facilitator: Pawin Puapornpong
Burden of Diabetes in Pregnancy
UOG Journal Club: March 2016
Screening for High Risk Pregnancy Peter Hornnes
DIP, GDM; CLINICAL IMPORTANCE AND NEW WHO DIAGNOSTIC CRITERIA FOR GDM
Parity and incidence of diabetes Mellitus
Screening for Diabetes in Pregnancy
Inonu University, Turgut Ozal Medical Centre
Insulin Resistance and serum Leptin levels in women with Gestational Diabetes Mellitus GÖKÇE ANIK İLHAN Yasemin Emiroğlu Çekiç1, Gökçe Anık İlhan2, Kadir.
PLASMA HOMOCYSTEINE LEVELS AS A PREDICTOR
A Study on Gestational Diabetes in Eastern India
Vitamin D insufficiency, preterm delivery and preeclampsia in women with type 1 diabetes – an observational study MARIANNE VESTGAARD1,2,3 , ANNA L. SECHER1,2.
Association between maternal circulating 25 hydroxyvitamin D concentration and placental volume in the first trimester Çiğdem Yayla Abide 1 Meryem Kurek.
Epidemiology of Gestational diabetes in Rural Wardha
Department of Obstetrics & Gynecology
The effect of metformin treatment of GDM-patients
Angiogenic factors in preeclampsia
Introduction Materials and Methods Results Conclusions
L. Bozkurt1, C. S. Göbl2 , A.-T. Hörmayer1, Anton Luger1, Sabina Baumgartner-Parzer1, A. Kautzky-Willer1 Implications of pregestational overweight.
Dietary treatment in gestational diabetes: Relation to birth weight
Capacity Building for Prevention of Complication from Gestational Diabetes in Public health system, UP Dr Rajesh Jain Project Manager Diabetes Prevention.
Investigation of early prognostic factors in the development of early onset preeclampsia Nilay Karaca MD.
Gestational Diabetes Lab 4.
UOG Journal Club: July 2012 Maternal hemodynamics at 11–13 weeks’ gestation and risk of pre-eclampsia A. Khalil, R. Akolekar, A. Syngelaki, M. Elkhouli.
Screening for Diabetes in Pregnancy
The relation of pentraxin-3 with preeclampsia and its severity
GESTATIONAL DIABETES RISKS AND FUTURE. GESTATIONAL DIABETES RISKS AND FUTURE.
Obstetric Cholestasis (lntrahepatic cholestasis of pregnancy):
Homeostasis model assessment of insulin resistance (HOMA-IR) scores in obese women and obese women with gestational diabetes mellitus (GDM) at approximately.
UOG Journal Club: September 2019
UOG Journal Club: October 2019
Presentation transcript:

IS THERE AN ASSOCIATION OF SERUM PLACENTAL GROWTH FACTOR LEVELS IN PREGNANT WOMEN WITH GDM? Ümit Görkem1, Cihan ToğruL1, Emine Arslan1, Nafiye Yılmaz2, Tayfun Güngör2 1-Hitit University Faculty of Medicine, Obstetrics and Gynecology 2- ZTB Maternal Health Training and Education Hospital

INTRODUCTION- OBJECTIVE Placental growth factor (PlGF) secreted by the syncytiotrophoblast is found in the maternal circulation beginning in the sixth week of gestation. Placental growth factor [PlGF] is a placenta- derived angiogenic protein involved in the regulation of placental vascular development [1]. 1- Maynard SE, et al. J Clin Invest 2003;111: 649–58.

PlGF has been extensively investigated as a first trimester biomarker for pregnancy complications related to impaired placentation such as preeclampsia and birth weight deviations [2-4]. Also, inclusion of serum PlGF improves the performance of first-trimester screening test for trisomy 21 [5]. . 2- Levine RJ, et al. N Engl J Med 2004;350:672–83. 3- Akolekar R, et al.Ultrasound Obstet Gynecol 2008;32:732–9. 4- Poon LC, et al. Prenat Diagn 2008;28:1110–5. 5- Pandya P, et al. Fetal Diagn Ther 2012;31:87–93.

Previous studies by Ong and Syngelaki et al Previous studies by Ong and Syngelaki et al. found increased serum PlGF levels in gestational diabetes (GDM) [6,7]. A recently published study also presented significantly higher first-trimester PlGF values in the GDM group [8] . Another recent study did not find a relationship between PLGF measured at 11–14 weeks and subsequent GDM among 328 women recruited prospectively [9]. 6- Syngelaki A, et al. Metabolism. 2015;64(11):1485– 9. 7- Ong CY, et al. J Reprod Med. 2004;49(6):477–80. 8- Eleftheriades M, et al. Metabolism 2014; 63: 1419–1425. 9- Mosimann B et al. . Fetal Diagn Ther. 2016;39:287–91.

At present, these findings remain contradictory. However, newer data found that serum PlGF was decreased in women with diabetes mellitus type 1 and in those with type 2 disease [8]. At present, these findings remain contradictory. Therefore, we aimed to investigate the associations of maternal serum placental growth factor (PlGF) levels with gestational diabetes mellitus (GDM). 8- Tsiakkas A, et al. Ultrasound Obstet Gynecol 2015; 45: 591–598.

MATERIAL-METHODS This cross-sectional study was underwent in the Obstetrics and Gynecology Department of Hitit University between March, 2015 and September, 2015. A total of 158 pregnant women were screened between 24 and 28 weeks of gestation. All of the low risk pregnant women were evaluated with a 50-g glucose challenge test (GCT). Women with serum glucose ≥ 140 mg/dL at 1 h after GCT were subjected to a 100-g oral glucose tolerance test (OGTT).

Pregnant women who met the inclusion criteria were divided into two groups; 76 of the GDM group, 82 of the control group. Maternal serum concentrations of PlGF, insulin and homeostasis model assessment- insulin resistance(HOMA-IR) were assessed.

Vasculogenesis and angiogenesis are essential for placental development and the VEGF family has been shown to play a key role [10]. A recent meta-analysis of studies investigating postpartum placental histology derived from pregnancies complicated by GDM demonstrates that there is increased placental volume, higher incidence of villous immaturity and increased angiogenesis [11]. 10- Geva E, et al. J Clin Endocrinol Metab 2002; 87:4213–4224. 11- Huynh J, et al. Placenta 2015; 36: 101–114.

Particularly the fetoplacental vasculature and endothelium were shown to be susceptible to hyperglycemia [12]. Fetal hyperinsulinism as a result of maternal hyperglycemia stimulates placental angiogenesis [13]. Therefore, an increase in angiogenic markers such as PlGF might be a consequence of these alterations. 12- Cvitic S, et al. Biomed Res Int 2014; 2014: 145846. 13- Lassance L, et al. J Clin Endocrinol Metab 2013; 98:e1438–e1447.

CONCLUSION We revealed that the serum PlGF levels were significantly increased in pregnants with GDM. PlGF seems to have a role in pathogenesis and early GDM diagnosis. Early identification of women at high risk for GDM could lead to an earlier diagnosis of the condition and improve the pregnancy outcomes.

Thank you for your attention